Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 67296-1485

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 67296-1485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructureatropine (Chemstructure 01)

Chemical structure diagram of Diphenoxylate Hydrochloride and Atropine Sulfate, depicting the molecular formula with labeled atoms and bonds, including a sulfate and water component shown as H2SO4 and H2O.*

FDA Label Image

Chemicalstructurediphen (Chemstructure)

Chemical structure of diphenoxylate hydrochloride, showing the molecular arrangement of its atoms and bonds as part of the active ingredients diphenoxylate hydrochloride and atropine sulfate tablet.*

FDA Label Image

Container2.5-0.025mg1000cc (Container2p5 0p025mg1000cc)

Label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, 2.5 mg/0.025 mg oral tablets. The label indicates a quantity of 1000 tablets, marked as prescription only. It includes the NDC 69315-910-10 and lists Redpharm Drug Inc. as the labeler. The label also contains dosage, storage, and pharmacist cautions, as well as a barcode and revision number 02.*

FDA Label Image

Container2.5-0.025mg100cc (Container2p5 0p025mg100cc)

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets USP, 2.5 mg/0.025 mg oral tablets, packaged by Leading Pharma. The label indicates 100 tablets per bottle, with prescription-only status. Includes instructions and cautionary information in small print, along with manufacturer and distributor details.*

FDA Label Image

Container2.5-0.025mg90cc (Container2p5 0p025mg90cc)

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, oral tablet dosage form, containing 2.5 mg diphenoxylate hydrochloride and 0.025 mg atropine sulfate per tablet. The package is labeled by Leading Pharma and contains 90 tablets. It displays prescription-only status, NDC 69315-910-09, and includes storage and usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.